What is Lincoln Diagnostics?
Lincoln Diagnostics operates as an independent diagnostic laboratory, offering comprehensive histopathology and clinical testing services. The company utilizes modern facilities equipped with advanced instrumentation and staffed by licensed technologists to ensure precise specimen preparation and analysis. Its services span a full spectrum of histology, molecular oncology, clinical blood testing, toxicology screening, and specialized diagnostics. By conducting all testing in-house, Lincoln Diagnostics aims to minimize turnaround times and maintain direct quality control, ensuring rapid and accurate reporting.
How much funding has Lincoln Diagnostics raised?
Lincoln Diagnostics has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
What's next for Lincoln Diagnostics?
With its recent large-scale late-stage funding, Lincoln Diagnostics is poised for significant growth and strategic development. The infusion of capital is expected to fuel advancements in its technological capabilities, potentially expanding its service offerings in areas like molecular oncology and specialized diagnostics. This strategic investment signals confidence in the company's business model and its capacity to enhance diagnostic precision and operational efficiency within the competitive healthcare landscape.
See full Lincoln Diagnostics company page
